Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation
- 1 June 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 294 (5) , 1023-1029
- https://doi.org/10.1016/s0006-291x(02)00595-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Epidermal Growth Factor Receptor Transactivation by Angiotensin II Requires Reactive Oxygen Species in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- N-Acetylcysteine Inhibits Angiotensin II-Mediated Activation of Extracellular Signal-Regulated Kinase and Epidermal Growth Factor ReceptorBiochemical and Biophysical Research Communications, 2001
- The multiple actions of angiotensin II in atherosclerosisRegulatory Peptides, 2000
- Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinaseRegulatory Peptides, 2000
- Angiotensin II receptor antagonistsThe Lancet, 2000
- Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin IIEuropean Journal of Pharmacology, 1999
- Angiotensin II Type 1 Receptor–Induced Extracellular Signal–Regulated Protein Kinase Activation Is Mediated by Ca 2+ /Calmodulin-Dependent Transactivation of Epidermal Growth Factor ReceptorCirculation Research, 1998
- Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1998
- Angiotensin II Signaling in Vascular Smooth MuscleHypertension, 1997
- Angiotensin Receptors and Their AntagonistsNew England Journal of Medicine, 1996